Proton pump inhibitors and pneumonia: the debate continues

January 2009
Gut;Jan2009, Vol. 58 Issue 1, p126
Academic Journal
The article presents the author's view on the study suggesting that proton pump inhibitor (PPI) use is associated with community-acquired pneumonia (CAP). The author relates that the use of PPI was defined as any scrip for PPI within 30 days of the diagnosis of CAP. Conditional logistic regression was performed to adjust for potential confounding, including age, gender, co-morbidity, and numerous medication that could either compromise the respiratory system or cause immunosuppression.


Related Articles

  • PPIs raise pneumonia risk. Moberly, Tom // GP: General Practitioner;5/29/2009, p8 

    The article presents a study on the development of pneumonia by using the proton pump inhibitors (PPIs) in the U.S. The findings of this study is contradicted by the use of the acid-suppressive medication because there is no supporting evidence of its ability to increase the risk of pneumonia in...

  • The Prevalence of and the Clinical and Demographic Characteristics Associated With High-Intensity Proton Pump Inhibitor Use. Targownik, Laura E.; Metge, Colleen; Roos, Leslie; Leung, Stella // American Journal of Gastroenterology;May2007, Vol. 102 Issue 5, p942 

    INTRODUCTION: High-intensity proton pump inhibitor (PPI) use is often recommended by physicians, though there is little proven benefit over standard PPI dosing in many clinical situations. We therefore sought to calculate the prevalence and predictors of high-intensity PPI use. METHODS: We used...

  • SIDE EFFECT: PNEUMONIA? Song, Sora // Time;11/8/2004, Vol. 164 Issue 19, p109 

    Reports that a study in the Journal of the American Medical Association says that proton-pump inhibitors such as Nexium or Prevacid may put you at risk for pneumonia. Findings from Dutch researchers that users of the drugs were 89 percent more likely to develop pneumonia than people who no...

  • Study finds PPI pneumonia link.  // Pulse;5/24/2007, Vol. 67 Issue 20, p12 

    The article focuses on the risk of proton pump inhibitors (PPI) to patients with pneumonia in Great Britain. Study shows that PPI raise pneumonia risk five-fold in the first week after its initiation. It was found out that the use of PPI increased the risk by 50 percent. The risk rose to 400...

  • Gastric acid suppression is associated with increased risk of pneumonia.  // BMJ: British Medical Journal (International Edition);1/22/2005, Vol. 330 Issue 7484, precedes p. 155 p155 

    Discusses whether the use of acid suppressing drugs increases the risk of community acquired pneumonia. Details of a study of patients taking acid suppressing drugs; Conclusion that current of such drugs, including H2 receptor antagonists and proton pump inhibitors, is associated with a...

  • GERD therapy and pneumonia. Karnack, Charles M.; Jungnicke, Paul W. // Drug Topics;12/13/2004, Vol. 148 Issue 23, THE HEALTH-SYSTEM PHARMACIST p9 

    This article presents a question and answer advisory regarding the use of proton pump inhibitor (PPI) in treating gastroesophageal reflux disease (GERD) given the documented risk of pneumonia. Usually, PPI is used for documented or high risk of gastrointestinal bleeding, persistent symptomatic...

  • Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm. Moayyedi, Paul; Cranney, Ann // American Journal of Gastroenterology;Oct2008, Vol. 103 Issue 10, p2428 

    Gastroenterology is full of examples of drugs being enthusiastically promoted only to be withdrawn or prescription curtailed once the harms of the medication are realized. Cox-2 inhibitors, alosetron, and tegaserod are all recent examples of this phenomenon. The problem is that potential harms...

  • The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease. Dekel, Roy; Morse, Chad; Fass, Ronnie // Drugs;2004, Vol. 64 Issue 3, p277 

    The proton pump inhibitors (PPIs) are the most successful class of drugs that have been introduced for the treatment of gastro-oesophageal reflux disease (GORD) because of their profound and consistent effect on gastric acid secretion. The PPIs have demonstrated an excellent adverse effect...

  • Stomach Acid Goes Down, Pneumonia Risk Goes Up. Dunkin, Mary Anne; Siegfried, Donna Rae // Arthritis Today;Mar/Apr2005, Vol. 19 Issue 2, p60 

    Deals with a study which found that the people who took acid-blocking drugs called proton-pump inhibitors were more likely to develop pneumonia as those not taking the drugs. Details of how reducing the stomach acid can lead to problems such as bronchitis and pneumonia; Impact on people who are...


Read the Article


Sign out of this library

Other Topics